NCT02562586

Brief Summary

The goal of this study was to compare early results of Total Hip Replacement (THR) in 2 groups of patients: with and without closed suction drainage (CSD). Patients were followed for 3 months post operatively.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
92

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2014

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2014

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2015

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2015

Completed
16 days until next milestone

First Submitted

Initial submission to the registry

August 17, 2015

Completed
1 month until next milestone

First Posted

Study publicly available on registry

September 29, 2015

Completed
Last Updated

September 29, 2015

Status Verified

September 1, 2015

Enrollment Period

1 year

First QC Date

August 17, 2015

Last Update Submit

September 28, 2015

Conditions

Keywords

SuctionArthroplastyReplacementHip

Outcome Measures

Primary Outcomes (1)

  • Change from baseline red blood cells (RBC)

    total RBC loss (mL) = \[Uncompensated RBC loss (mL)\] + \[Compensated RBC loss (mL)\] Uncompensated RBC loss (mL) = \[Initial RBC (mL)\] - \[Final RBC (mL)\] Compensated RBC loss (mL) = \[Sum of RBCs received from the various sources of transfusion\] Initial RBC (mL) = \[Estimated blood volume (mL)\] x \[Initial Hct level (%)\] at Day -1 Final RBC (mL) = \[Estimated blood volume (mL)\] x \[Final Hct level (%)\] at Day +3 Estimated blood volume (mL) = Women: \[Body surface area (m2)\] x 2430 Men: \[Body surface area (m2)\] x 2530 Body surface area (m2) = 0.0235 x \[Height (cm)\]0.42246 x \[Weight (kg)\]0.51456 Total blood loss at Hct level of 35% (mL) = \[Total blood loss (mL)\] / 0.35

    Pre-operative and 24 Hours Postoperative

Secondary Outcomes (4)

  • Mid thigh circumference (cm)

    Pre-operative and 24 Hours Postoperative to 3 Months Postoperative

  • C-Reactive Protein (CRP) (mg/L)

    3,6 and 12 Weeks Postoperative

  • Erythrocyte sedimentation rate (ESR) (mm/h)

    3,6 and 12 Weeks Postoperative

  • Complications

    during 3 months follow-up

Other Outcomes (2)

  • Visual Analogue Scale for Pain

    Pre-operative and 24 Hours Postoperative

  • Harris Hip Score Questionnaire

    Pre-operative and 3 Months Postoperative

Study Arms (2)

Closed Suction Drainage System

ACTIVE COMPARATOR

Group 1: patients undergoing total hip replacement received a Closed Suction Drainage System for 24 hours after the surgical procedure

Device: Closed Suction Drainage System

No Closed Suction Drainage System

NO INTERVENTION

Group 2: patients undergoing total hip replacement have not received a Closed Suction Drainage System after the surgical procedure

Interventions

patients undergoing total hip replacement have received a closed suction drainage for 24 hours after the surgical procedure

Closed Suction Drainage System

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Primary Hip Arthroplasty
  • Lateral Hardinge Approach
  • Non-cemented Acetabular and Femoral Components
  • Length of Skin Incision between 10 and 20 cm

You may not qualify if:

  • Coagulative Disorders
  • Previous Surgery in the same limb
  • Age below 18 years old

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Instituto Ortopedia e Traumatologia do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo IOT-HCFMUSP

São Paulo, São Paulo, 05403-010, Brazil

Location

Related Publications (6)

  • Zhou XD, Li J, Xiong Y, Jiang LF, Li WJ, Wu LD. Do we really need closed-suction drainage in total hip arthroplasty? A meta-analysis. Int Orthop. 2013 Nov;37(11):2109-18. doi: 10.1007/s00264-013-2053-8. Epub 2013 Aug 28.

    PMID: 23982636BACKGROUND
  • Gonzalez Della Valle A, Slullitel G, Vestri R, Comba F, Buttaro M, Piccaluga F. No need for routine closed suction drainage in elective arthroplasty of the hip: a prospective randomized trial in 104 operations. Acta Orthop Scand. 2004 Feb;75(1):30-3. doi: 10.1080/00016470410001708050.

    PMID: 15022802BACKGROUND
  • Chen ZY, Gao Y, Chen W, Li X, Zhang YZ. Is wound drainage necessary in hip arthroplasty? A meta-analysis of randomized controlled trials. Eur J Orthop Surg Traumatol. 2014 Aug;24(6):939-46. doi: 10.1007/s00590-013-1284-0. Epub 2013 Aug 6.

    PMID: 23917702BACKGROUND
  • Ovadia D, Luger E, Bickels J, Menachem A, Dekel S. Efficacy of closed wound drainage after total joint arthroplasty. A prospective randomized study. J Arthroplasty. 1997 Apr;12(3):317-21. doi: 10.1016/s0883-5403(97)90029-2.

    PMID: 9113547BACKGROUND
  • Strahovnik A, Fokter SK, Kotnik M. Comparison of drainage techniques on prolonged serous drainage after total hip arthroplasty. J Arthroplasty. 2010 Feb;25(2):244-8. doi: 10.1016/j.arth.2008.08.014. Epub 2008 Dec 4.

    PMID: 19056215BACKGROUND
  • Willett KM, Simmons CD, Bentley G. The effect of suction drains after total hip replacement. J Bone Joint Surg Br. 1988 Aug;70(4):607-10. doi: 10.1302/0301-620X.70B4.3403607.

    PMID: 3403607BACKGROUND

MeSH Terms

Conditions

Osteoarthritis, Hip

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Study Officials

  • Jose Ricardo Negreiros Vicente, MD PhD

    Hip Surgery Group Instituto Ortopedia e Traumatologia do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo IOT-HCFMUSP

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of Hip Surgery Group

Study Record Dates

First Submitted

August 17, 2015

First Posted

September 29, 2015

Study Start

May 1, 2014

Primary Completion

May 1, 2015

Study Completion

August 1, 2015

Last Updated

September 29, 2015

Record last verified: 2015-09

Locations